-
Consumer Insights
NewMass Affluent Banking in Greater China – Regional Breakdown by Market Trends, Investment Preferences and Competitor Benchmarking
Mass Affluent Banking Market in Greater China Report Overview Emerging affluents and mass affluents make up most of the affluent population in the Greater China region. The population of affluents has been exponential in the last decade in the region. However, the growth is expected to slow down in the upcoming years as the economies mature. Despite low growth, the number of mass affluent customers in the region is exceedingly large, offering a huge market to the financial providers looking...
-
Product Insights
NewLikelihood of Approval Analysis for Male Hypogonadism
Overview How likely is it that the drugs in Male Hypogonadism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Male Hypogonadism Overview Male hypogonadism is a condition in which the body...
-
Product Insights
NewLikelihood of Approval Analysis for Vaginal Cancer
Overview How likely is it that the drugs in Vaginal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vaginal Cancer Overview Vaginal cancer is a rare cancer that occurs in...
-
Product Insights
NewLikelihood of Approval Analysis for Anal Cancer
Overview How likely is it that the drugs in Anal Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anal Cancer Overview Anal cancer starts in the anus. Symptoms include rectal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Post Menopausal Osteoporosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Post Menopausal Osteoporosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Post Menopausal Osteoporosis Drug Details: Denosumab biosimilar...
-
Product Insights
NewLikelihood of Approval Analysis for Gastrointestinal Stromal Tumor (GIST)
Overview How likely is it that the drugs in Gastrointestinal Stromal Tumor (GIST) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastrointestinal Stromal Tumor (GIST) Overview Gastrointestinal stromal tumors (GISTs) are...
-
Product Insights
NewLikelihood of Approval Analysis for Anaplastic Thyroid Cancer
Overview How likely is it that the drugs in Anaplastic Thyroid Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anaplastic Thyroid Cancer Overview Anaplastic thyroid cancer (ATC) is a rare...
-
Product Insights
NewLikelihood of Approval Analysis for Malignant Fibrous Histiocytoma of Soft Tissue
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma of Soft Tissue will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma of Soft Tissue Overview Malignant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sotagliflozin in Hypertrophic Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sotagliflozin in Hypertrophic Cardiomyopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sotagliflozin in Hypertrophic Cardiomyopathy Drug Details: Sotagliflozin (Zynquista, Inpefa) is a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ONCase-PEG in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONCase-PEG in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONCase-PEG in Breast Cancer Drug Details: rMETase (ONCase-PEG) is under development for...